Publicaciones en colaboración con investigadores/as de Hospital Universitario de la Princesa (26)

2023

  1. Toxicity of Asciminib in Real Clinical Practice: Analysis of Side Effects and Cross-Toxicity with Tyrosine Kinase Inhibitors

    Cancers, Vol. 15, Núm. 4

  2. Usefulness of Preoperative Determination of Serum MR-ProAdrenomedullin Levels to Predict the Need for Postoperative Organ Support in Abdominal Oncological Surgery

    Journal of Personalized Medicine, Vol. 13, Núm. 7

2022

  1. Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

    Haematologica, Vol. 107, Núm. 11, pp. 2675-2684

  2. Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity

    British Journal of Pharmacology, Vol. 179, Núm. 11, pp. 2733-2753

  3. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  4. Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

    Annals of Hematology, Vol. 101, Núm. 10, pp. 2263-2270

2021

  1. Gestión del proceso posanalítico en los laboratorios clínicos según los requisitos de la norma ISO 15189:2012. Consideraciones sobre la revisión, notificación y comunicación de los resultados

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 61-70

  2. Management of post-Analytical processes in the clinical laboratory according to ISO 15189:2012. Considerations about the management of clinical samples, ensuring quality of post-Analytical processes, and laboratory information management

    Advances in Laboratory Medicine, Vol. 2, Núm. 3, pp. 373-380

  3. Management of postanalytical processes in the clinical laboratory according to ISO 15189:2012 Standard requirements: Considerations on the review, reporting and release of results

    Advances in Laboratory Medicine, Vol. 2, Núm. 1, pp. 51-59

2020

  1. Myeloid GRK2 regulates obesity-induced endothelial dysfunction by modulating inflammatory responses in perivascular adipose tissue

    Antioxidants, Vol. 9, Núm. 10, pp. 1-17

  2. The interaction between mitochondrial oxidative stress and gut microbiota in the cardiometabolic consequences in diet-induced obese rats

    Antioxidants, Vol. 9, Núm. 7, pp. 1-15

2017

  1. Corrigendum to "T Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced Damage"

    BioMed research international

  2. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia

    British Journal of Cancer, Vol. 117, Núm. 2, pp. 256-265

2015

  1. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

    American Journal of Hematology, Vol. 90, Núm. 5, pp. 429-433

  2. Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke

    European Journal of Medicinal Chemistry, Vol. 101, pp. 604-615

  3. T helper 17/regulatory t cell balance and experimental models of peritoneal dialysis-induced damage

    BioMed Research International, Vol. 2015

2014

  1. IL-17A is a novel player in dialysis-induced peritoneal damage

    Kidney International, Vol. 86, Núm. 2, pp. 303-315

2013

  1. Vardenafil Improves Penile Erection in Type 2 Diabetes Mellitus Patients with Erectile Dysfunction: Role of Tropomyosin

    Journal of Sexual Medicine, Vol. 10, Núm. 12, pp. 3110-3120

2011

  1. Longitudinal studies of ischemic penumbra by using 18F-FDG PET and MRI techniques in permanent and transient focal cerebral ischemia in rats

    NeuroImage, Vol. 57, Núm. 1, pp. 45-54

2009

  1. A nanoconjugate Apaf-1 inhibitor protects mesothelial cells from cytokine-induced injury

    PLoS ONE, Vol. 4, Núm. 8